We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · June 30, 2020

Efficacy of Nusinersen in Type 1, 2, and 3 Spinal Muscular Atrophy

European Journal of Paediatric Neurology


Additional Info

European Journal of Paediatric Neurology
Efficacy of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Real World Data from Hungarian Patients
Eur. J. Paediatr. Neurol. 2020 May 14;[EPub Ahead of Print], L Szabó, A Gergely, R Jakus, A Fogarasi, Z Grosz, MJ Molnár, I Andor, O Schulcz, Á Goschler, E Medveczky, D Czövek, Á Herczegfalvi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading